IQVIA Holdings Inc
Solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients, faster.
The CALM Studies are looking at an investigational drug to see if it can help ***s with chronic cough.
Co-pay Program benefit overview and enrollment, re-enrollment, and sign in portal for program-eligible patients and healthcare professionals.
Delivering flexible clinical development solutions designed for the specific needs of biotech companies.
The ABTECT Study is an ulcerative colitis (UC) clinical research trial evaluating how safe an investigational *** is and whether it works to help those with UC.
Are you pregnant? Do you have uterine fibroids or endometriosis? Have you taken Orilissa or Oriahnn? You may be able to help other moms-to-be.
Co-pay Program benefit overview and enrollment, re-enrollment, and sign in portal for program-eligible patients and healthcare professionals.
copay program benefit overview and enrollment, re-enrollment, and sign in portal for program-eligible patients and healthcare professionals.
ims health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance.
See if you or your child can join an eosinophilic asthma clinical trial. Help us learn more about a potential new medicine for eosinophilic asthma.
Do you have dry, cracked, itchy, or inflamed skin due to moderate to severe atopic dermatitis (AD)? Are you or your child aged 12 to 64 years old? Our clinical research study may be for you. You or your child must have tried and not responded to a treatment that can affect the whole body (systemic treatment) or must have been medically advised to not use topical treatments.
The RELEASE Study is looking at how safe an investigational *** is and whether it improves depression for people with bipolar I disorder.
human papillomavirus (hpv) vaccine clinical research study evaluating how safe the investigational vaccine is and whether it works to induce an immune response against hpv compared with an approved vaccine. if you are female, between 16-26 years of age, you may be able to participate.
Clinical research study to evaluate a potential new *** (investigational ***) as a possible treatment for COVID-19. We are looking for *** participants who have symptoms of COVID-19 but do not currently need hospital or emergency care.
